These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32344315)

  • 1. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome.
    Assimakopoulos SF; Marangos M
    Med Hypotheses; 2020 Apr; 140():109778. PubMed ID: 32344315
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence.
    Mohanty RR; Padhy BM; Das S; Meher BR
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2802-2807. PubMed ID: 33829465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
    Nagarkatti P; Miranda K; Nagarkatti M
    Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
    Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
    Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study.
    Li XQ; Liu H; Meng Y; Yin HY; Gao WY; Yang X; Xu DS; Cai XD; Guan Y; Lerman LO; Peng ZY; Zhou HR
    J Med Virol; 2021 Dec; 93(12):6641-6652. PubMed ID: 34314040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
    Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
    Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
    Mehta Y; Dixit SB; Zirpe KG; Ansari AS
    Indian J Crit Care Med; 2020 Jun; 24(6):429-434. PubMed ID: 32863636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases.
    Horowitz RI; Freeman PR; Bruzzese J
    Respir Med Case Rep; 2020; 30():101063. PubMed ID: 32322478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of
    Schloss J; Leach M; Brown D; Hannan N; Kendall-Reed P; Steel A
    Adv Integr Med; 2020 Dec; 7(4):232-239. PubMed ID: 32837898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and treatment of cytokine storm in COVID-19.
    Soy M; Keser G; Atagündüz P
    Turk J Biol; 2021; 45(4):372-389. PubMed ID: 34803441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biphasic phenomenon of cytokine storm in COVID pneumonia.
    Shah NM; Khambholja JR; Suthar NN; Purohit HM
    Ann Afr Med; 2022; 21(2):168-172. PubMed ID: 35848652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
    Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
    Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
    Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
    J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
    Horowitz RI; Freeman PR
    Med Hypotheses; 2020 Oct; 143():109851. PubMed ID: 32534175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.
    Khodadadi H; Salles ÉL; Jarrahi A; Chibane F; Costigliola V; Yu JC; Vaibhav K; Hess DC; Dhandapani KM; Baban B
    Cannabis Cannabinoid Res; 2020; 5(3):197-201. PubMed ID: 32923657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.